Abstract
Periodontitis drives irreversible destruction of periodontal tissue and is prone to exacerbating inflammatory disorders. Systemic immunomodulatory management continues to be an attractive approach in periodontal care, particularly within the context of "predictive, preventive, and personalized" periodontics. In the present study, genetic proxies identified through genome-wide association studies (GWAS) for circulating immune cells and periodontitis were incorporated into a comprehensive Mendelian randomization (MR) framework. Univariable MR, multivariable MR, subgroup analysis, reverse MR, and Bayesian model averaging (MR-BMA) were utilized to investigate the causal relationships. Furthermore, transcriptome-wide association study (TWAS) and colocalization analysis were deployed to pinpoint the underlying genes. Consequently, the MR study indicated a causal association between circulating neutrophils, natural killer T cells, plasmacytoid dendritic cells, and an elevated risk of periodontitis. MR-BMA analysis revealed that neutrophils were the primary contributors to periodontitis. The high-confidence genes S100A9 and S100A12, located on 1q21.3, could potentially serve as immunomodulatory targets for neutrophil-mediated periodontitis. These findings hold promise for early diagnosis, risk assessment, targeted prevention, and personalized treatment of periodontitis. Considering the marginal association observed in our study, further research is required to thoroughly comprehend the biological underpinnings and ascertain the clinical relevance.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by the Major Program of National Natural Science Foundation of China (No. 81991500 & 81991502), the Fundamental Research Funds for the Central Universities (No. 226-2023-00121 & 226-2022-00213), Zhejiang University Global Partnership Fund (No. 188170 & 194452307/004) and the Joint Funds of the Zhejiang Provincial Natural Science Foundation of China (No. LHDMD23H300001)
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study used (or will use) ONLY openly available human data that were originally located at: Data from GLIDE can be obtained via application (https://data.bris.ac.uk/data/dataset/), FinnGen can be obtained via application (href="https://finngen.gitbook.io/documentation/v/r9/data-download), and GTEx can be obtained via application (https://gtexportal.org/home).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Tittle changed. Section on page 14 updated to note the shortcoming of using multiple selection thresholds for IVs. Section on page 6-7 updated to clarify the reason for selecting Smoking, Fasting plasma glucose, and BMI as covariates. Section on page 15 updated to state our limitation of excessive focus on systemic immunological changes. Lines 78-80 on page 3 were revised to clarify the increase in both monocytes and B cells. Lines 164-165 on page 7 were revised for clarity. The section on page 6 was revised to clarify the meaning of robust. Section on page 12 updated to incorporate suggested literature into our revised manuscript.
Data Availability
The data generated or analysed during this study are available in this published article and its supplementary information files. The data used in the study could be requested through the corresponding author with reasonable request.
https://data.bris.ac.uk/data/dataset/
